Company Filing History:
Years Active: 2013
Title: Andrea Waltenberger: Innovator in Cancer Diagnosis and Treatment
Introduction
Andrea Waltenberger is a prominent inventor based in Horn, Austria. She has made significant contributions to the field of cancer research, particularly in the development of antibodies for the diagnosis and treatment of melanoma. Her innovative work has the potential to improve cancer detection and therapeutic strategies.
Latest Patents
Andrea holds a patent for "Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein." This invention provides antibodies, or fragments thereof, for isolating and identifying epitopes of an endogenous retrovirus, specifically targeting melanoma-associated endogenous retroviruses. The antibodies developed through this patent are particularly useful for the treatment and diagnosis of cancer. Additionally, the patent covers diagnostic kits for detecting cancer cells, especially melanoma cells, and methods for cancer diagnosis using these antibodies.
Career Highlights
Andrea is currently associated with Baxter Healthcare SA, where she continues to advance her research in cancer diagnostics. Her work has garnered attention for its potential impact on improving patient outcomes in oncology.
Collaborations
Andrea collaborates with notable colleagues, including Johannes Humer and Bernd Mayer, who contribute to her research efforts and innovations in the field.
Conclusion
Andrea Waltenberger's contributions to cancer research through her innovative patents and collaborations highlight her role as a key figure in the fight against melanoma. Her work exemplifies the importance of innovation in medical science and its potential to save lives.